About Brightspring Health Services Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.brightspringhealth.com/
Frequently Asked Questions
What is the 52-week range for BTSG?
The 52-week high is $73.7499 and the 52-week low is $27.11.
What is the P/E ratio for BTSG?
The Price to Earnings (P/E) ratio is 32.57.
What is the dividend yield for BTSG?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 18.96%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 2.55%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.60.
Analyst Recommendation Trends
Wall Street analyst consensus for BTSG over the last few months:
Latest BTSG News
Why BrightSpring Health Services (BTSG) Stock Is Up Today
Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 4.8% in the afternoon session after BMO Capital analyst Sean Dodge reiterated an Outperform rating and a $70 price target on the company, StreetInsider reported.
BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026
LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2026 financial results on Friday, October 30, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on t
BTSG Deploys AI Across Operations: Will It Improve Margins?
BrightSpring Health Services is expanding AI and automation across its operations, with early margin gains and more benefits expected later in 2026 and 2027.
Option Care Health (OPCH) Draws Fresh Home Care Attention, Is It Still 20% Undervalued?
Option Care Health (OPCH) is back in focus after fresh commentary compared its home and alternate site infusion business with BrightSpring Health Services, highlighting how both could benefit as complex treatments continue shifting into lower cost home settings. Recent trading tells a mixed story. Option Care Health’s share price is up 8.41% over the past 90 days but down 29.25% year to date, while the 1 year total shareholder return has declined 17.83%, which may hint at fading momentum...
BrightSpring vs. Option Care Health: Which Healthcare Stock Is Better?
BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contrast with OPCH's slower growth and chronic-therapy pressures.
BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI
BrightSpring Health Services (NASDAQ:BTSG) outlined its growth strategy across pharmacy and provider services at the Bernstein healthcare services conference, emphasizing specialty pharmacy expansion, home health acquisitions, technology investments and opportunities to integrate services for comple
3 Market-Beating Stocks to Research Further
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.
Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?
BTSG's stronger cash flow and lower leverage could give it more flexibility to pursue acquisitions and support future growth.
Best Momentum Stocks to Buy for September 24th
RDVT, BTSG and THC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 24th, 2026.
BrightSpring Health Services (BTSG) Wins Fund Backing, Is It Still Undervalued?
BrightSpring Health Services (BTSG) is back on investor radar after Carillon Eagle Small Cap Growth Fund highlighted the healthcare provider in its second quarter 2026 letter, citing revenue and adjusted EBITDA ahead of IPO expectations. Despite the upbeat fund commentary, BrightSpring Health Services has hit a softer patch on the screen, with the share price at US$56.55 after a 1-day share price return of 1.24% but a 90-day share price return that has declined 16.36%. The year-to-date share...
Zacks.com featured highlights include Centene, BrightSpring Health Services and Delek US
Momentum stocks Centene, BrightSpring Health Services and Delek US show strong annual gains despite recent weekly pullbacks.
2 Russell 2000 Stocks to Research Further and 1 We Avoid
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
3 Momentum Anomaly Stocks to Buy as Markets Surge on AI Rally
Centene, BrightSpring and Delek combine 52-week gains with short-term pullbacks, putting them in focus as momentum plays for volatile markets.
Here’s What Lifted BrightSpring Health Services (BTSG)
Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. The letter can be downloaded here. Small-cap stocks rallied broadly in the second quarter, with the Russell 2000 Growth Index (+25.71%) outpacing Value +17.24%). Information Technology (+46.79%) led all sectors, supported by solid gains […]
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.
Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.
IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know
IQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
BrightSpring Health Services, Inc. (BTSG) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
BrightSpring Health Services, Inc. (BTSG) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 3:20 PM EDTCompany ParticipantsJennifer...
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.
3 Cash-Producing Stocks with Exciting Potential
Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically for growth.
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?
BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.
BrightSpring Health Services: 44% Ebitda Growth Is Hard To Ignore
BrightSpring Health's premium 34.38x FY1 P/E is justified by strong EBITDA growth and a forward PEG of 0.73x. Find out why BTSG stock is a buy.
BrightSpring: Why Flat Prescription Volume Is Not The Number To Watch
BrightSpring may benefit from the RASONQUE debut. Click for this BTSG stock update and see if it is the right play for you.
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside
NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stocks positioned for market volatility.
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
3 Lesser-Known Stocks Wall Street Is Pounding the Table on Now
William Blair’s latest Conviction List is putting three under-the-radar stocks, BJ’s Restaurants, APi Group, and BrightSpring Health Services, in the spotlight.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-14 | Greenwell Scott A. | -11,973 | - | - |
| 2026-09-14 | Greenwell Scott A. | -15,099 | $57.91 | $874,383 |
| 2026-09-14 | Greenwell Scott A. | +11,973 | $22.27 | $266,639 |
| 2026-07-25 | ROUSSEAU JON B | -56,319 | $72.91 | $4,106,218 |
| 2026-06-20 | Greenwell Scott A. | -2,487 | $66.25 | $164,764 |
| 2026-06-11 | Shah Nigam H. | +4,013 | - | - |
| 2026-06-05 | Nalley Lisa A | -35,000 | - | - |
| 2026-06-05 | Nalley Lisa A | -35,000 | $58.75 | $2,056,250 |
| 2026-06-05 | Nalley Lisa A | +35,000 | $6.37 | $222,950 |
| 2026-06-05 | Phipps Jennifer A | -35,000 | - | - |
| 2026-06-05 | Phipps Jennifer A | -35,000 | $58.75 | $2,056,250 |
| 2026-06-05 | Phipps Jennifer A | +35,000 | $6.37 | $222,950 |
| 2026-06-05 | KKR Americas Fund XII L.P. | -23,263 | - | - |
| 2026-06-05 | KKR Americas Fund XII L.P. | -36,927 | - | - |
| 2026-06-05 | KKR Americas Fund XII L.P. | -324,608 | - | - |
| 2026-06-05 | KKR Americas Fund XII L.P. | -14,669,771 | $58.453 | $857,492,124 |
| 2026-06-05 | ROUSSEAU JON B | -130,000 | - | - |
| 2026-06-05 | ROUSSEAU JON B | -130,000 | - | - |
| 2026-06-05 | ROUSSEAU JON B | -130,000 | $58.75 | $7,637,500 |
| 2026-06-05 | ROUSSEAU JON B | +130,000 | $6.37 | $828,100 |
| 2026-06-05 | ROUSSEAU JON B | -130,000 | $58.75 | $7,637,500 |
| 2026-06-05 | ROUSSEAU JON B | +130,000 | $6.37 | $828,100 |
| 2026-06-05 | KRAVIS HENRY R | -23,263 | - | - |
| 2026-06-05 | KRAVIS HENRY R | -36,927 | - | - |
| 2026-06-05 | KRAVIS HENRY R | -324,608 | - | - |
| 2026-06-05 | KRAVIS HENRY R | -14,669,771 | $58.453 | $857,492,124 |
| 2026-05-05 | Miller Steven B | +4,983 | - | - |
| 2026-05-05 | Wicks Timothy A | +4,983 | - | - |
| 2026-05-05 | KIRTLEY OLIVIA F | +4,983 | - | - |
| 2026-04-25 | ROUSSEAU JON B | -16,222 | $48.16 | $781,252 |
| 2026-03-30 | Barnes Robert Allen | -6,748 | $41.54 | $280,312 |
| 2026-03-20 | ROUSSEAU JON B | +192,704 | - | - |
| 2026-03-20 | ROUSSEAU JON B | -192,704 | - | - |
| 2026-03-20 | ROUSSEAU JON B | +192,704 | - | - |
| 2026-03-20 | ROUSSEAU JON B | -192,704 | - | - |
| 2026-03-20 | ROUSSEAU JON B | +180,753 | - | - |
| 2026-03-20 | ROUSSEAU JON B | -180,753 | - | - |
| 2026-03-05 | Greenwell Scott A. | +49,073 | - | - |
| 2026-03-05 | Greenwell Scott A. | +20,020 | - | - |
| 2026-03-05 | Nalley Lisa A | +52,344 | - | - |
| 2026-03-05 | Nalley Lisa A | +21,354 | - | - |
| 2026-03-05 | Phipps Jennifer A | +130,860 | - | - |
| 2026-03-05 | Phipps Jennifer A | +53,384 | - | - |
| 2026-03-05 | ROUSSEAU JON B | +458,008 | - | - |
| 2026-03-05 | ROUSSEAU JON B | +186,845 | - | - |
| 2026-03-04 | Nalley Lisa A | -30,000 | - | - |
| 2026-03-04 | Nalley Lisa A | +3,925 | - | - |
| 2026-03-04 | Nalley Lisa A | +35,331 | - | - |
| 2026-03-04 | Nalley Lisa A | -30,000 | $41.15 | $1,234,500 |
| 2026-03-04 | Nalley Lisa A | +30,000 | $6.37 | $191,100 |
| 2026-03-04 | Phipps Jennifer A | -35,000 | - | - |
| 2026-03-04 | Phipps Jennifer A | +5,888 | - | - |
| 2026-03-04 | Phipps Jennifer A | +35,331 | - | - |
| 2026-03-04 | Phipps Jennifer A | -35,000 | $41.15 | $1,440,250 |
| 2026-03-04 | Phipps Jennifer A | +35,000 | $6.37 | $222,950 |
| 2026-03-04 | ROUSSEAU JON B | -220,000 | - | - |
| 2026-03-04 | ROUSSEAU JON B | +955,823 | - | - |
| 2026-03-04 | ROUSSEAU JON B | -220,000 | $41.15 | $9,053,000 |
| 2026-03-04 | ROUSSEAU JON B | +220,000 | $6.37 | $1,401,400 |
| 2026-03-04 | KKR Americas Fund XII L.P. | -31,918 | - | - |
| 2026-03-04 | KKR Americas Fund XII L.P. | -49,295 | - | - |
| 2026-03-04 | KKR Americas Fund XII L.P. | -402,773 | - | - |
| 2026-03-04 | KKR Americas Fund XII L.P. | -19,715,000 | $40.961 | $807,546,115 |
| 2026-03-04 | KRAVIS HENRY R | -31,918 | - | - |
| 2026-03-04 | KRAVIS HENRY R | -49,295 | - | - |
| 2026-03-04 | KRAVIS HENRY R | -402,773 | - | - |
| 2026-03-04 | KRAVIS HENRY R | -19,715,000 | $40.961 | $807,546,115 |
| 2026-03-03 | Barnes Robert Allen | +2,944 | - | - |
| 2026-03-03 | Barnes Robert Allen | +35,331 | - | - |
| 2026-01-25 | Phipps Jennifer A | -33,190 | $39.64 | $1,315,652 |
| 2026-01-25 | Nalley Lisa A | -20,556 | $39.64 | $814,840 |
| 2026-01-25 | Barnes Robert Allen | -6,972 | $39.64 | $276,370 |
| 2026-01-25 | ROUSSEAU JON B | -49,304 | $39.64 | $1,954,411 |
| 2025-11-05 | Miller Steven B | -4,497 | $32.68 | $146,962 |
| 2025-10-25 | ROUSSEAU JON B | -58,746 | $33.53 | $1,969,753 |
| 2025-10-25 | ROUSSEAU JON B | -49,796 | $33.53 | $1,669,660 |
| 2025-10-22 | Nalley Lisa A | -20,000 | - | - |
| 2025-10-22 | Nalley Lisa A | -20,000 | $28.782 | $575,640 |
| 2025-10-22 | Nalley Lisa A | +20,000 | $6.37 | $127,400 |
| 2025-10-22 | KKR Americas Fund XII L.P. | -39,493 | - | - |
| 2025-10-22 | KKR Americas Fund XII L.P. | -50,484 | - | - |
| 2025-10-22 | KKR Americas Fund XII L.P. | -409,305 | - | - |
| 2025-10-22 | KKR Americas Fund XII L.P. | -14,745,000 | $28.782 | $424,390,590 |
| 2025-10-22 | ROUSSEAU JON B | -235,000 | - | - |
| 2025-10-22 | ROUSSEAU JON B | -235,000 | $28.782 | $6,763,770 |
| 2025-10-22 | ROUSSEAU JON B | +235,000 | $6.37 | $1,496,950 |
| 2025-10-22 | KRAVIS HENRY R | -39,493 | - | - |
| 2025-10-22 | KRAVIS HENRY R | -50,484 | - | - |
| 2025-10-22 | KRAVIS HENRY R | -409,305 | - | - |
| 2025-10-22 | KRAVIS HENRY R | -14,745,000 | $28.782 | $424,390,590 |